Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.

Journal: European urology focus
Published Date:

Abstract

BACKGROUND: Focal therapy (FT) with its favorable side-effect profile represents an option between active surveillance and traditional whole-gland treatment in localized prostate cancer (PCa). Consensus statements recommend eligibility criteria based on magnetic resonance imaging (MRI)-targeted and systematic combination biopsy.

Authors

  • Jost von Hardenberg
    Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: jost.vonhardenberg@medma.uni-heidelberg.de.
  • Angelika Borkowetz
    Department of Urology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Fabian Siegel
    Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Heinrich-Lanz Center, Department of Biomedical Informatics, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Kira Kornienko
    Department of Urology, Charité University Medicine Berlin, Berlin, Germany.
  • Niklas Westhoff
    Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Tobias B Jordan
    Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Manuela Hoffmann
    Department of Occupational Health and Safety, Federal Ministry of Defense, Bonn, Germany.
  • Martin Drerup
    Department of Urology, Paracelsus Medical University, Salzburg, Austria.
  • Verena Lieb
    Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Germany.
  • Kasra Taymoorian
    Outpatient Urology Practice, Koblenz, Germany.
  • Martin Schostak
    Clinic of Urology, Urooncology, Robotic-assisted and Focal Therapy, Medical Faculty and University Clinics of Magdeburg, Magdeburg, Germany.
  • Roman Ganzer
    Department of Urology, Asklepios Hospital Bad Tölz, Bad Tölz, Germany.
  • Thomas Höfner
    Department of Urology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Hannes Cash
    Department of Urology, Charité University Medicine Berlin, Berlin, Germany.
  • Johannes Bruendl
    Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.